| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1992 Faculty of Public Health Medicine of the Royal Colleges of Physicians of the United Kingdom
research-article |
Discounting in health care decision-making: time for a change?
Trevor A. Sheldon, Lecturer in Medical Statistics
Academic Unit of Public Medicine, University of Leeds 30 Hyde Terrace, Leeds LS2 9LN
Economic appraisal is increasingly being used to inform health care decisionmaking. To allow comparison, costs and benefits spread over time are weighted according to when they are experienced. The further in the future, the less heavily they are weighted or the more they are discounted. Traditional economic appraisal techniques are based on the view that social decisions should reflect private preferences. The practice of discounting future streams of costs and benefits is principally justified by the fact that individuals have a positive time preference, preferring consumption sooner rather than later. Discounting weights public decisionmaking in favour of interventions resulting in short-term benefits and against longer-term benefits. This discriminates against preventive and other public health programmes. This paper provides a critique of the foundations of discounting. It is argued that health policy should have a longer time horizon, reflecting social values rather than individual preferences. Factors which make discounting the future rational from the individual's point of view are shown to be irrelevant to a societal perspective. Although uncertainty about the effectiveness of interventions and technological change are good reasons for weighting some future benefits less highly, the routine use of a single discount rate for economic evaluations of health programmes is not justified
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Lai, J. Habicht, and R.-A. Kiivet Measuring burden of disease in Estonia to support public health policy Eur J Public Health, October 1, 2009; 19(5): 541 - 547. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Shaw, C. N. B. Merz, C. J. Pepine, S. E. Reis, V. Bittner, K. E. Kip, S. F. Kelsey, M. Olson, B. D. Johnson, S. Mankad, et al. The Economic Burden of Angina in Women With Suspected Ischemic Heart Disease: Results From the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation Circulation, August 29, 2006; 114(9): 894 - 904. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Krumholz, W. S. Weintraub, W. D. Bradford, P. A. Heidenreich, D. B. Mark, and A. D. Paltiel Task Force #2--the cost of prevention: can we afford it? Can we afford not to do it? J. Am. Coll. Cardiol., August 21, 2002; 40(4): 603 - 615. [Full Text] [PDF] |
||||
![]() |
D. J Torgerson and J. Raftery Economics notes: Discounting BMJ, October 2, 1999; 319(7214): 914 - 915. [Full Text] |
||||
![]() |
M. Johannesson, J. S. Pliskin, and M. C. Weinstein A Note on QALYs, Time Tradeoff, and Discounting Med Decis Making, April 1, 1994; 14(2): 188 - 193. [Abstract] [PDF] |
||||




